Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Lymphoma

  Free Subscription


31.07.2017

1 Am J Hematol
5 Blood
1 Br J Dermatol
3 Br J Haematol
1 Cancer
1 Eur J Immunol
2 Haematologica
3 Leuk Lymphoma
2 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. ARMITAGE JO
    The aggressive peripheral T-cell lymphomas: 2017.
    Am J Hematol. 2017;92:706-715.
    PubMed     Text format     Abstract available


    Blood

  2. CONNORS JM, Ansell SM, Fanale M, Park SI, et al
    Five-year follow-up of brentuximab vedotin combined with ABVD or AVD for advanced stage classical Hodgkin lymphoma.
    Blood. 2017 Jul 21. pii: blood-2017-05-784678. doi: 10.1182/blood-2017-05-784678
    PubMed     Text format    


  3. Predicting transformation of follicular lymphoma.
    Blood. 2017;130:383.
    PubMed     Text format    

  4. GONG S, Hijiya N
    Classical Hodgkin lymphoma and Castleman disease: a rare morphologic combination.
    Blood. 2017;130:381.
    PubMed     Text format    

  5. FEHNIGER TA
    CD70 turns on NK cells to attack lymphoma.
    Blood. 2017;130:238-239.
    PubMed     Text format    

  6. CABANILLAS F, Rivera N
    Check this checkpoint inhibitor in lymphoma.
    Blood. 2017;130:234-235.
    PubMed     Text format    


    Br J Dermatol

  7. BAUER WM, Aichelburg MC, Griss J, Skrabs C, et al
    Molecular Classification of Tumor Cells in a Patient with Intravascular Large B-Cell Lymphoma.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15841.
    PubMed     Text format     Abstract available


    Br J Haematol

  8. DELLA PEPA R, Picardi M, Giordano C, Zacheo I, et al
    Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.
    Br J Haematol. 2017 Jul 24. doi: 10.1111/bjh.14856.
    PubMed     Text format    

  9. CASCIONE L, Rinaldi A, Chiappella A, Kwee I, et al
    Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study.
    Br J Haematol. 2017 Jul 24. doi: 10.1111/bjh.14817.
    PubMed     Text format    

  10. SHIVAROV V, Ivanova M
    Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data.
    Br J Haematol. 2017 Jul 24. doi: 10.1111/bjh.14861.
    PubMed     Text format    


    Cancer

  11. EPPERLA N, Maddocks KJ, Salhab M, Chavez JC, et al
    C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.
    Cancer. 2017 Jul 27. doi: 10.1002/cncr.30895.
    PubMed     Text format     Abstract available


    Eur J Immunol

  12. DUAULT C, Betous D, Bezombes C, Roga S, et al
    IL-33-expanded human Vgamma9Vdelta2 T cells have anti-lymphoma effect in a mouse tumor model.
    Eur J Immunol. 2017 Jul 25. doi: 10.1002/eji.201747093.
    PubMed     Text format     Abstract available


    Haematologica

  13. MONDELAERS V, Suciu S, De Moerloose B, Ferster A, et al
    Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951.
    Haematologica. 2017 Jul 27. pii: haematol.2017.165845.
    PubMed     Text format     Abstract available

  14. JALLADES L, Baseggio L, Sujobert P, Huet S, et al
    Exome sequencing identifies recurrent BCOR gene alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.
    Haematologica. 2017 Jul 27. pii: haematol.2016.160192.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  15. SANCHEZ-GONZALEZ B, Torres E, Ferraro Rosset MP, Calafell M, et al
    Rituximab subcutaneous in B-cell non-Hodgkin lymphoma: clinical experience in a single center.
    Leuk Lymphoma. 2017 Jul 21:1-3. doi: 10.1080/10428194.2017.1349906.
    PubMed     Text format    

  16. SHLIAKHTSITSAVA K, Romero SAD, Dewald SR, Su HI, et al
    Pregnancy and child health outcomes in pediatric and young adult leukemia and lymphoma survivors: a systematic review.
    Leuk Lymphoma. 2017 Jul 21:1-17. doi: 10.1080/10428194.2017.1352097.
    PubMed     Text format     Abstract available

  17. SANTIAGO V, Lazaryan A, McClune B, McKenna RW, et al
    Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome.
    Leuk Lymphoma. 2017 Jul 21:1-9. doi: 10.1080/10428194.2017.1352094.
    PubMed     Text format     Abstract available


    Leukemia

  18. CHEADLE EJ, Lipowska-Bhalla G, Dovedi SJ, Fagnano E, et al
    A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.
    Leukemia. 2017 Jul 28. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  19. YAO Z, Deng L, Xu-Monette ZY, Manyam GC, et al
    Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy.
    Leukemia. 2017 Jul 12. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: